InfiCure Bio AB (private company)

See something wrong or missing? Let us know
Offices:Umeå
Business model:B2B

InfiCure Bio is a life science company, doing work on a unique preclinical model for studies of fibrosis and working with pharmaceutical companies to test their new anti-inflammatory/anti-fibrotic drugs in the unique preclinical model.

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to InfiCure Bio AB

Name Criteria
France AbolerIS Pharma
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Sweden Athera
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Sweden AttgeNO
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Sweden Cinclus Pharma
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Denmark Oui
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Finland DelSiTech
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Sweden Gradientech
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Sweden iCellate
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Sweden Ilya Pharma
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Finland Nanoform Finland
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Top